Download Brochure



Biolevox HA 2.2% 44mg


FOR ONLINE ORDER


Biolevox HA 2.2% 44mg

Biolevox HA 2.2% is a hyaluronic acid (HA) gel designed for intra-articular injection to alleviate symptoms of osteoarthritis (OA) in synovial joints. Each 2 ml pre-filled syringe contains 44 mg of sodium hyaluronate, providing an optimal 2.2% concentration.

Key Features

  • High Molecular Weight Hyaluronate: Ranges from 1.4 to 2.4 MDa, ensuring optimal viscosity and elasticity for effective joint lubrication and shock absorption.
  • Proven Efficacy: Clinical studies indicate that three consecutive weekly injections can reduce OA symptoms for at least six months.
  • Convenient Packaging: Supplied in a sterile, ready-to-use 2 ml pre-filled syringe for easy administration.

Indications

Biolevox HA 2.2% is intended for patients experiencing pain and limited joint mobility due to post-traumatic or degenerative changes, such as osteoarthritis, in large joints like the knee, hip, and shoulder.

Administration

The recommended regimen consists of three intra-articular injections, each administered one week apart. This treatment plan has been shown to provide symptom relief for a minimum of six months. If necessary, the therapy cycle can be repeated.

Contraindications

  • Known hypersensitivity to any of the product's components.
  • Presence of septic arthritis or skin infections at the injection site.
  • Patients undergoing anticoagulant therapy.
  • Not recommended for use in children, pregnant, or breastfeeding women due to insufficient clinical data.

Precautions

  • Ensure aseptic conditions during administration to prevent infections.
  • For intra-articular use only; avoid intravascular injection.
  • Do not use disinfectants containing quaternary ammonium salts, as they may cause hyaluronate precipitation.
  • Inspect the pre-filled syringe for damage before use; do not use if compromised.
  • Do not re-sterilize or reuse the syringe; it is intended for single use only.

Possible Side Effects

Some patients may experience temporary symptoms at the injection site, including:

  • Pain
  • Redness
  • Swelling

These symptoms can often be alleviated by applying a cold compress for 5-10 minutes post-injection. Consult a healthcare professional if side effects persist or worsen.

Storage

  • Store at temperatures between 2°C and 25°C.
  • Protect from moisture and direct sunlight.
  • Keep out of reach of children.

Composition

Each 1 ml of Biolevox HA 2.2% contains:

  • Sodium hyaluronate: 22.000 mg
  • Sodium chloride: 8.500 mg
  • Disodium hydrogen phosphate: 0.563 mg
  • Sodium dihydrogen phosphate: 0.045 mg
  • Water for injection: q.s.

For more detailed information, please refer to the product's official documentation or consult a healthcare professional.